2023
DOI: 10.1016/j.pupt.2023.102213
|View full text |Cite
|
Sign up to set email alerts
|

Weight loss in nintedanib-treated patients with idiopathic pulmonary fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…Thus, the efficacy of nintedanib in patients with PPFE remains controversial. Importantly, we suggest that nintedanib administration be considered only if maintenance of good physique in the patient is assumed because lower weight tends to be associated with weight loss, which is a common side effect of nintedanib, and nintedanib itself (and not ILD alone) may accelerate weight loss as an adverse event, thus leading to its early discontinuation [53,88]. Because long-term persistent use of nintedanib may lead to a favorable prognosis, maintenance of good physique is of major importance when considering that decreased BMI is related to disease progression in patients with PPFE [16].…”
Section: Proposed Management Algorithm For Ppfementioning
confidence: 99%
“…Thus, the efficacy of nintedanib in patients with PPFE remains controversial. Importantly, we suggest that nintedanib administration be considered only if maintenance of good physique in the patient is assumed because lower weight tends to be associated with weight loss, which is a common side effect of nintedanib, and nintedanib itself (and not ILD alone) may accelerate weight loss as an adverse event, thus leading to its early discontinuation [53,88]. Because long-term persistent use of nintedanib may lead to a favorable prognosis, maintenance of good physique is of major importance when considering that decreased BMI is related to disease progression in patients with PPFE [16].…”
Section: Proposed Management Algorithm For Ppfementioning
confidence: 99%